Opioid Overdose Prevention Toolkit (PDF - 885 KB KB)
Describes opioid overdose reversal medications in some detail, including a comparison of available formulations (Table 1, page 6), ending with information directed at a variety of audiences.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Describes opioid overdose reversal medications in some detail, including a comparison of available formulations (Table 1, page 6), ending with information directed at a variety of audiences.
This web page includes information on lifesaving medications approved by the Food and Drug Administration (FDA) to reverse an opioid overdose.
See Table 1 – 7-item measure of perceived organizational support for treating people with OUD. Response options are from 1 (strongly disagree) to 5 (strongly agree).
This page from Penn State Project ECHO provides an overview of various knowledge networks and topics currently supported by the initiative.
This is a guide for scoring the PTSD Checklist for DSM-5 (PCL-5) that was posted by the Canadian ADHD Resource Alliance (CADDRA).
This page provides info on free and low-cost medications for patients who struggle to afford them.
State-level policy information related to telehealth, including for Medicaid, Medicare and parity for private insurance.